Research study Program year 2020 Source: CMS Open Payments

Scgam-06

ClinicalTrials.gov NCT03939533

Research payments

$336,183

61 payments

Through program year 2020, $336,183 in research payments was reported against Scgam-06, across 61 payments, paid by Octapharma USA, Inc..

Paid by: Octapharma USA, Inc.
ClinicalTrials.gov: NCT03939533

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$274,741	48
2019	Research	$61,442	13

Breakdown

Who paid Research payments · program years 2019–2020

Octapharma USA, Inc. $336,183 61 payments

Who received the money Research payments · program years 2019–2020

Uci Medical Center Teaching hospital · CA $52,094 3 payments
Allergy Associates Of The Palm Beaches Organisation paid for research $44,767 6 payments
BTC Network Organisation paid for research $42,073 5 payments
Allergy And Clinical Immunology Associates Organisation paid for research $34,831 10 payments
University of South Florida Organisation paid for research $27,608 4 payments
Medical Research Of Arizona Organisation paid for research $22,627 4 payments
Toledo Institute Of Clinical Research Organisation paid for research $21,270 3 payments
Midlands Pediatrics Pc Organisation paid for research $18,574 3 payments
Bernstein Clinical Research Organisation paid for research $17,610 5 payments
Midlands Pediatrics Organisation paid for research $15,760 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.